Our findings demonstrate that anti-MSLN uCAR-like NK cells not only possess exceptional tumor penetration and homing capabilities but also exhibit potent antitumor activity against MSLN-positive tumors, laying the foundation for their clinical application. Here, MSLN is linked to neoplasm.